loadpatents
name:-0.028477191925049
name:-0.018515110015869
name:-0.0078990459442139
Mayes; Benjamin Alexander Patent Filings

Mayes; Benjamin Alexander

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mayes; Benjamin Alexander.The latest application filed is for "d-amino acid compounds for liver disease".

Company Profile
6.17.28
  • Mayes; Benjamin Alexander - Boston MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
2',4'-bridged nucleosides for HCV infection
Grant 10,723,754 - Mayes , et al.
2020-07-28
D-amino acid compounds for liver disease
Grant 10,717,758 - Mayes , et al.
2020-07-21
4'-or nucleosides for the treatment of HCV
Grant 10,683,321 - Dukhan , et al.
2020-06-16
2'-chloro nucleoside analogs for HCV infection
Grant 10,513,534 - Gosselin , et al. Dec
2019-12-24
D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
Grant 10,238,680 - Mayes , et al.
2019-03-26
Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of HCV
Grant 10,231,986 - Dukhan , et al.
2019-03-19
D-amino Acid Compounds For Liver Disease
App 20180258130 - MAYES; Benjamin Alexander ;   et al.
2018-09-13
4'-or Nucleosides For The Treatment Of Hcv
App 20180162898 - Dukhan; David ;   et al.
2018-06-14
Pharmaceutical Compositions Comprising A 5,5-fused Heteroarylene Flaviviridae Inhibitor And Their Use For Treating Or Preventing Flaviviridae Infection
App 20170135990 - Moussa; Adel M. ;   et al.
2017-05-18
Solid Prodrug Forms Of 2'-chloro-2'-methyl Uridine For Hcv
App 20170066795 - Sulliva-Bolyai; John Zoltan ;   et al.
2017-03-09
Solid Forms Of A Flaviviridae Virus Inhibitor Compound And Salts Thereof
App 20170066779 - Moussa; Adel M. ;   et al.
2017-03-09
Cyclopentane And Cyclopentene Nucleoside Analogs For The Treatment Of Hcv
App 20160280729 - Moussa; Adel M. ;   et al.
2016-09-29
D-alanine Phosphoramide Pronucleotides Of 2'-methyl 2'-fluro Guanosine Nucleoside Compounds For The Treatment Of Hcv
App 20160271162 - Moussa; Adel M. ;   et al.
2016-09-22
Thiophosphate nucleosides for the treatment of HCV
Grant 9,339,541 - Dousson , et al. May 17, 2
2016-05-17
Amino Acid Phosphoramidate Pronucleotides Of 2'-cyano, Azido And Amino Nucleosides For The Treatment Of Hcv
App 20160113956 - DUKHAN; David ;   et al.
2016-04-28
3'-deoxy nucleosides for the treatment of HCV
Grant 9,309,275 - Stewart , et al. April 12, 2
2016-04-12
2'-chloro Nucleoside Analogs For Hcv Infection
App 20160083413 - Gosselin; Gilles ;   et al.
2016-03-24
D-amino Acid Phosphoramidate Pronucleotides Of Halogeno Pyrimidine Compounds For Liver Disease
App 20160082030 - Mayes; Benjamin Alexander ;   et al.
2016-03-24
D-amino Acid Compounds For Liver Disease
App 20160002281 - MAYES; Benjamin Alexander ;   et al.
2016-01-07
4'-fluoro nucleosides for the treatment of HCV
Grant 9,211,300 - Mayes , et al. December 15, 2
2015-12-15
Esters and malonates of SATE prodrugs
Grant 9,192,621 - Mayes , et al. November 24, 2
2015-11-24
2',4'-fluoro nucleosides for the treatment of HCV
Grant 9,187,515 - Mayes , et al. November 17, 2
2015-11-17
3',5'-cyclic phosphoramidate prodrugs for HCV infection
Grant 9,109,001 - Parsy , et al. August 18, 2
2015-08-18
D-amino Acid Phosphoramidate Pronucleotides Of Halogeno Pyrimidine Compounds For Liver Disease
App 20150037282 - MAYES; Benjamin Alexander ;   et al.
2015-02-05
2',4'-fluoro Nucleosides For The Treatment Of Hcv
App 20140294769 - MAYES; Benjamin Alexander ;   et al.
2014-10-02
Thiophosphate Nucleosides For The Treatment Of Hcv
App 20140248242 - DOUSSON; Cyril B. ;   et al.
2014-09-04
3'-deoxy Nucleosides For The Treatment Of Hcv
App 20140248241 - STEWART; Alistair James ;   et al.
2014-09-04
4'-fluoro Nuclosides For The Treatment Of Hcv
App 20140178338 - MAYES; Benjamin Alexander ;   et al.
2014-06-26
D-Alanine Ester of Sp-Nucleoside Analog
App 20140140952 - MOUSSA; Adel M. ;   et al.
2014-05-22
D-Alanine Ester of Rp-Nucleoside Analog
App 20140140951 - MOUSSA; Adel M. ;   et al.
2014-05-22
Dinucleotide Compounds For Hcv Infection
App 20140112886 - MOUSSA; Adel M. ;   et al.
2014-04-24
2',4'-bridged Nucleosides For Hcv Infection
App 20140112887 - MAYES; Benjamin Alexander ;   et al.
2014-04-24
2'-chloro Nucleoside Analogs For Hcv Infection
App 20140099283 - GOSSELIN; Gilles ;   et al.
2014-04-10
Esters and Malonates of SATE Prodrugs
App 20140086873 - Mayes; Benjamin Alexander ;   et al.
2014-03-27
D-amino Acid Compounds For Liver Disease
App 20130315868 - MAYES; Benjamin Alexander ;   et al.
2013-11-28
3',5'-cyclic Phosphoramidate Prodrugs For Hcv Infection
App 20130315866 - PARSY; Christophe Claude ;   et al.
2013-11-28
Pharmaceutical Compositions of 2'-C-Methyl-Guanosine, 5'-[2[(3-Hydroxy-2,2-Dimethyl-1-Oxopropyl)Thio]Ethyl N-(Phenylmethyl)Phosphoramidate]
App 20130217644 - MAYES; Benjamin Alexander ;   et al.
2013-08-22
Enantiomerically pure phosphoindoles as HIV inhibitors
Grant 8,486,991 - Storer , et al. July 16, 2
2013-07-16
Macrocyclic serine protease inhibitors
Grant 8,093,379 - Moussa , et al. January 10, 2
2012-01-10
Enantiomerically Pure Phosphoindoles As Hiv Inhibitors
App 20110257129 - Storer; Richard ;   et al.
2011-10-20
Enantiomerically pure phosphoindoles as HIV inhibitors
Grant 7,960,428 - Storer , et al. June 14, 2
2011-06-14
Process for preparing a synthetic intermediate for preparation of branched nucleosides
Grant 7,781,576 - Mayes , et al. August 24, 2
2010-08-24
Enantiomerically pure phosphoindoles as HIV inhibitors
App 20080213217 - Storer; Richard ;   et al.
2008-09-04
Process for preparing a synthetic intermediate for preparation of branched nucleosides
App 20070203334 - Mayes; Benjamin Alexander ;   et al.
2007-08-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed